Prospective action plan on development of gastro retentive floating tablets
Journal name: World Journal of Pharmaceutical Research
Original article title: Prospective action plan on development of gastro retentive floating tablets
The WJPR includes peer-reviewed publications such as scientific research papers, reports, review articles, company news, thesis reports and case studies in areas of Biology, Pharmaceutical industries and Chemical technology while incorporating ancient fields of knowledge such combining Ayurveda with scientific data.
This page presents a generated summary with additional references; See source (below) for actual content.
Original source:
This page is merely a summary which is automatically generated hence you should visit the source to read the original article which includes the author, publication date, notes and references.
Saikh Mahammed Athar Alli
World Journal of Pharmaceutical Research:
(An ISO 9001:2015 Certified International Journal)
Full text available for: Prospective action plan on development of gastro retentive floating tablets
Source type: An International Peer Reviewed Journal for Pharmaceutical and Medical and Scientific Research
Copyright (license): WJPR: All rights reserved
Download the PDF file of the original publication
Summary of article contents:
INTRODUCTIONGastro retentive floating tablets (GRFT) are a promising solution to overcome the challenges of short gastric residence time (GRT) and unpredictable gastric emptying time (GET) in oral drug delivery systems. These tablets are designed to remain in the upper part of the gastrointestinal (GI) tract for an extended period, providing controlled drug release and improving bioavailability.
ACTION PLAN FOR DEVELOPMENT
Developing effective GRFT requires a detailed action plan that includes selecting appropriate systems and formulations. GRFT can be designed using various approaches such as high-density systems, magnetic systems, floating systems, mucoadhesive systems, expandable systems, superporous hydrogels, or dual working systems. The choice of system depends on the drug's characteristics, desired release profile, and target area within the GI tract. Researchers must consider the properties of different polymers, plasticizers, and methods like effervescence and mucoadhesion to achieve the desired performance and buoyancy.
GASTRO RETENTIVE FLOATING TABLETS
GRFT are versatile in their applications, suitable for drugs that require specific site absorption in the stomach or duodenum, are intended for local action, or degrade in the colon. They minimize drug degradation, improve bioavailability, and enhance patient compliance. However, GRFTs are not suitable for drugs that are insoluble, unstable in the GI tract, irritate the gastric mucosa, undergo first-pass metabolism, or require release in the colon. The systems are designed to release drugs slowly while remaining buoyant in gastric fluids, with a significant constraint being the need for a high level of fluid in the stomach and maintaining an upright position.
PROSPECTIVE ACTION PLAN OF DEVELOPMENT
Strategies for developing GRFT include using polymers like hydroxypropyl cellulose, HPMC, and ethyl cellulose to control the drug release and buoyancy. The systems may involve microparticles, effervescent materials, or mucoadhesive components. The formulation requires precise control over polymer type and quantity, plasticizer-polymer ratios, and incorporation of hydrophilic materials to enhance performance. Evaluating GRFT includes tests for floating time, drug content, mechanical properties, and release kinetics. Advanced techniques like MRI, X-ray diffraction, and differential scanning calorimetry are employed for in-depth analysis.
CONCLUSION
Successful development of GRFT necessitates a thorough understanding of the drug's physiochemical properties, GI tract physiology, and appropriate formulation strategies. There must be a correlation between in vitro and in vivo performances, considering factors like the presence of food and the complex motility of the stomach. Advanced technologies will facilitate the creation of GRFT that optimize drug delivery for regional absorption within the GI tract.
FAQ section (important questions/answers):
What is the purpose of gastro retentive floating tablets (GRFT)?
GRFTs aim to improve gastric residence time (GRT) and provide controlled drug release, enhancing patient compliance and convenience.
What are the advantages of GRFT?
GRFTs retain the drug in the stomach, minimize degradation in the colon, and improve the bioavailability of many drugs.
What limitations do GRFTs have?
GRFTs are unsuitable for drugs that are insoluble in the GI tract, require release in the colon, or undergo first-pass metabolism. They also need a high fluid level in the stomach and upright positioning.
What types of systems can be used to create GRFTs?
GRFTs can be developed using high-density, magnetic, floating, mucoadhesive, expandable, superporous hydrogel systems, and dual-working systems.
What materials are involved in the formulation of GRFTs?
GRFTs can use polymers like HPMC, hydroxypropyl cellulose, crospovidone, ethyl cellulose, and various others. Effervescent compounds and gas-filled chambers are also utilized.
How are GRFTs evaluated for effectiveness?
GRFT effectiveness is evaluated based on floating time, buoyancy, specific gravity, swelling study, content uniformity, in vitro and in vivo performance, and physicochemical interactions.
Glossary definitions and references:
Scientific and Ayurvedic Glossary list for “Prospective action plan on development of gastro retentive floating tablets�. This list explains important keywords that occur in this article and links it to the glossary for a better understanding of that concept in the context of Ayurveda and other topics.
1) Drug:
Drug plays a central role in the development of gastro retentive floating tablets (GRFT). It refers to the active pharmaceutical ingredient that is intended to be absorbed in the stomach or duodenum, offering controlled or sustained release, improved bioavailability, and treating local gastric conditions such as ulcers and gastritis.
2) Ali (Āli, Aḷḷi):
Alli refers to Dr. Saikh Mahammed Athar Alli, the primary author of the research paper published in the World Journal of Pharmaceutical Research. He is an Assistant Professor in the Department of Pharmaceutical Sciences at Shiats (Deemed to be University), Allahabad, Uttar Pradesh, India, specializing in GRFT.
3) Science (Scientific):
Science underpins the entire research and development process described in the article. It involves understanding the physiological, chemical, and material sciences required to design, formulate, and optimize gastro retentive floating tablets. Scientific principles guide experimental design, problem-solving, and development of robust and effective GRFT systems.
4) Knowledge:
Knowledge is a fundamental component for the research discussed. It refers to the extensive understanding required of gastrointestinal physiology, material properties, drug dissolution and absorption kinetics, and formulation strategies to successfully develop and optimize gastro retentive floating tablets with the desired performance characteristics.
5) Swelling:
Swelling is a crucial mechanism utilized in certain GRFTs to achieve an extended gastric residence time. Tablet formulations that swell upon contact with gastric fluids form a gel barrier, increasing their size to prevent premature exit from the stomach while controlling drug release.
6) Quality:
Quality in the context of GRFT relates to the reproducibility, consistency, and performance of the final product throughout its shelf life. It encompasses various evaluations such as floating time, buoyancy, specific gravity, drug content uniformity, mechanical properties, and in vitro and in vivo performance.
7) Salt (Salty):
Salt, particularly in the form of effervescent compounds like bicarbonate salts, is employed in certain GRFT formulations. These salts react with gastric acids to produce gas, facilitating the floating mechanism crucial for prolonging the tablets' gastric residence time and ensuring controlled drug release.
8) Substance:
Substance in this context mainly refers to the active pharmaceutical ingredients and excipients used in the formulation of GRFT. It includes polymers, gel-forming agents, effervescent materials, and other components that contribute to the desired characteristics of the floating tablets.
9) Transformation (Transform, Transforming):
Transform relates to the physicochemical interactions and processes that occur during the preparation and administration of GRFT. Transformational aspects include the conversion of materials into a gel barrier, generating buoyant forces through effervescence, and the transition of microparticles to a swollen state in the stomach.
10) Water:
Water or gastric fluid plays a significant role in the functioning of GRFT. Upon contact with water in the stomach, certain excipients in the tablet swell, hydrate, or react to form a gel barrier, enabling the tablet to float and release the drug in a controlled manner.
11) Ulcer:
Ulcer treatment is one of the medical applications of GRFT. These tablets are advantageous for locally acting drugs on gastric mucosa, providing therapeutic benefits in conditions like peptic ulcers by maintaining a prolonged drug residence in the stomach and ensuring targeted drug delivery at the ulcer site.
Other Science Concepts:
Discover the significance of concepts within the article: �Prospective action plan on development of gastro retentive floating tablets�. Further sources in the context of Science might help you critically compare this page with similair documents:
Bioavailability, In vitro, Stability study, Controlled release, Sustained release, Magnetic resonance imaging, In vivo, First Pass Metabolism, Action plan, In vivo evaluation.